A Case of Immune Checkpoint Inhibitor Refractory Colitis Treated with Mycophenolate and High-dose Steroids

Immune checkpoint inhibitors (ICPI) are a class of chemotherapy agents that have emerged as a front-line treatment option for multiple cancers. Nivolumab is an ICPI agent commonly used to treat metastatic melanoma. Although promising, the adverse reaction of this class is broad and per reports, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcantar, Daniel, Al-Jaashaami, Layth, Giron, Fanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957235/
https://www.ncbi.nlm.nih.gov/pubmed/31938669
http://dx.doi.org/10.7759/cureus.6392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957235/
https://www.ncbi.nlm.nih.gov/pubmed/31938669
http://dx.doi.org/10.7759/cureus.6392

Ejemplares similares